Type of surgery | Number of procedures (n = 4001) | Median age- (25th-75th percentile) | Female gender - n (%) | Mortality – n (%) | All VTE – n (%; 95% CI) | PE – n (%; 95% CI) | DVT – n (%; 95% CI) |
---|---|---|---|---|---|---|---|
Total hip replacement | |||||||
-Degenerative hip disorder | 1691 | 71.1 (62–78) | 1101 (65.1) | 10 (0.6; 0.3-1.1) | 40 (2.4; 1.7-3.2) | 14 (0.8; 0.5-1.4) | 28 (1.7; 1.1-2.4) |
- Fracture | 348 | 78.5 (73–83) | 272 (78.2) | 9 (2.6; 1.3-5.0) | 10 (2.9; 1.5-5.3) | 3 (0.9; 0.3-2.7) | 7 (2.0; 1.0-4.2) |
- Fracture sequelae | 522 | 77.9 (70–84) | 392 (75.1) | 13 (2.5; 1.4-4.3) | 14 (2.7; 1.6-4.5) | 6 (1.2; 0.5-2.6) | 8 (1.5; 0.8-3.1) |
Hemiarthroplasty | |||||||
- hip fracture | 743 | 84.9 (80–89) | 565 (76.0) | 71 (9.6; 7.6-12.1) | 7 (0.9; 0.4-2.0) | 6 (0.8; 0.4-1.8) | 1 (0.1; 0.02-1.0) |
- Fracture sequelae | 239 | 84.9 (81–90) | 192 (80.3) | 15 (6.3; 3.8-10.4) | 3 (1.3; 0.4-3.9) | 0 | 3 (1.3; 0.4-3.9) |
Hip prosthesis revision | 429 | 74.8 (64–82) | 251 (58.5) | 3 (0.7; 0.2-2.2) | 5 (1.2; 0.5-2.8) | 0 | 5 (1.2; 0.5-2.8) |
Hip replacement - malignancy | 29 | 64.3 (58–78) | 21 (72.4) | 1 (3.4; 0.5-24.5) | 1 (3.4; 0.5-24.5) | 0 | 1 (3.4; 0.5-24.5) |